马来西亚分散临床试验 (DCT) 指导文件

《临床试验法规》(ctr)关于试验用药品(imps)标签的修订
Malaysia has released its first Decentralised Clinical Trial guidance document, which provides detailed guidance on implementing decentralised elements in clinical trials. The document was developed through collaboration between various stakeholders and can be used regardless of any health crisis. It is favourable to the industry and it is applicable now.
The document outlines how companies can incorporate DCT into their research while setting key parameters, rules and expectations.

抱歉,此优质内容仅供 RegASK 客户使用。

想要访问警报的全部内容或浏览所有新闻?